Analysts See 10% Upside For VTWG

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Russell 2000 Growth ETF (VTWG), we found that the implied analyst target price for the ETF based upon its underlying holdings is $121.89 per unit.

START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

With VTWG trading at a recent price near $110.70 per unit, that means that analysts see 10.11% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of VTWG's underlying holdings with notable upside to their analyst target prices are Second Sight Medical Products Inc ( EYES), La Jolla Pharmaceutical Co. ( LJPC), and Endocyte Inc ( ECYT). Although EYES has traded at a recent price of $2.03/share, the average analyst target is 688.18% higher at $16.00/share. Similarly, LJPC has 145.30% upside from the recent share price of $18.10 if the average analyst target price of $44.40/share is reached, and analysts on average are expecting ECYT to reach a target price of $6.50/share, which is 144.36% above the recent price of $2.66. Below is a twelve month price history chart comparing the stock performance of EYES, LJPC, and ECYT:

EYES, LJPC, and ECYT Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
Vanguard Russell 2000 Growth ETF VTWG $110.70 $121.89 10.11%
Second Sight Medical Products Inc EYES $2.03 $16.00 688.18%
La Jolla Pharmaceutical Co. LJPC $18.10 $44.40 145.30%
Endocyte Inc ECYT $2.66 $6.50 144.36%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
Get the latest Zacks research report on EYES — FREE
Get the latest Zacks research report on LJPC — FREE
Get the latest Zacks research report on ECYT — FREE

More from Stocks

Here's Why General Electric's Stock Isn't Falling Off a Cliff After Earnings

Here's Why General Electric's Stock Isn't Falling Off a Cliff After Earnings

What General Electric Shareholders Should Do Now

What General Electric Shareholders Should Do Now

General Electric, Honeywell, Wells Fargo and Qualcomm - 5 Things You Must Know

General Electric, Honeywell, Wells Fargo and Qualcomm - 5 Things You Must Know

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Will Tesla Stock Tumble 33% to $195?

Will Tesla Stock Tumble 33% to $195?